CTLs also affect the metabolism of glioma cells through IFN-γ, which activated casein kinase (CK)-2 of tumor cells to hold up glycolysis, impeding the growth of gliomas (Ghildiyal and Sen, 2017). Here, IFNG is linked to central nervous system cancer.